Date:2/9/2012

onditions in the parts of the world where TB is most often rampant. SomaLogic's breakthrough proteomic technology, based on protein-detecting reagents called "SOMAmers," provides clear advantages over current reagents and methods used in TB tests in terms of accuracy, sensitivity, stability (e.g., no need for refrigeration), ease of production and cost: In short, all of the attributes necessary to develop a POC diagnostic device for remote and resource-poor areas of the world.

In line with the Gates Foundation's Global Access policy, SomaLogic is committed to ensuring that the knowledge gained during this project is promptly and broadly disseminated, and that diagnostic tests that come from this work will be made available and accessible at a reasonable cost to the developing world.

'/>"/>

Contact: Fintan Steele, Ph.D. fsteele@somalogic.com 720‑214‑3080 SomaLogic, Inc. Source:Eurekalert

0 GOOD

Page: 1 2
Related biology news :

1. SomaLogic and Ambergen announce agreement for commercial applications of photocleavable biotin
2. SomaLogic announces agreement with leading global pharma company to accelerate R&D
3. SomaLogic and New England Biolabs announce agreement to use SOMAmers for multiple PCR products
4. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
5. St. Josephs receives Canadas first whole-body PET/MRI scanner
6. Rensselaer Professor Ryan Gilbert receives NSF CAREER award
7. WHOIs John Waterbury receives NAS Gilbert Morgan Smith Medal
8. SUNY Downstate receives grant from research to prevent blindness
9. Startup receives $4 million to develop drug delivery targeted to the back of the eye
10. University of Texas chemist receives major grant to improve detection of drug-resistant tuberculosis
11. Kessler Foundation neuroscientist Jordan Grafman receives Humboldt Research Award